AMAG Pharmaceuticals Inc (USD)
AMAG
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range5.91 | 6.31
52-Wk Range |
Last Close6.17
Mkt Cap (m)211.42
Dividend yield-
ISINUS00163U1060
Volume352,673
Exchange VenueNAS

Company Profile

AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.

Key Information
Price/Earning-
Price/Book0.74
Price/Sales0.64
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 08/05/2017
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)124418532610474-
Operating Income (m)713112544-64-
Net Income (m)13633-2-199-66-
Basic EPS6.061.04-0.07-5.71-1.91-
Avg. Diluted Shares Outstanding (m)2535343534-
Balance Sheet
USD201420152016201720182019
Current Assets (m)274607719482525-
Non Current Assets (m)1,1151,8811,7601,371650-
Total Assets (m)1,3892,4872,4781,8531,175-
Current Liabilities (m)166246313278165-
Total Liabilities (m)------
Total Equity (m)460932934790747-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)119624610861-
Capital Expenditure (m)-1-5-65-3-
Figures are quoted in USD unless stated otherwise
-0.09 (-1.38%)
$
6.09
Last Price